Vincenzi Bruno
Associate Professor
Medical Oncology
Universita Campus Bio-Medico di Roma
Italy
Biography
Vincenzi Bruno from 2011 - present Researcher, Medical Oncology, Campus Bio-Medico University of Rome (UCBM); 2007 - present Stagist, Medical Oncology Unit, Campus Bio-Medico University Hospital; 2004 - 2007 PhD in Cellular and Molecular Oncopathology, University of Palermo; 2000 - 2004 Specialisation diploma in Medical Oncology, Università Cattolica del Sacro Cuore, Rome; 2000 Degree in Medicine and Surgery, UCBM.
Research Interest
Multidisciplinary management of urogenital cancer; Physiopathology and treatment of skeletal metastasis; Translational research in oncology; Development of statistical models in oncology; Treatment of soft tissue sarcomas and of rare cancers; Treatment of gastrointestinal tumors (especially colorectal tumors and pancreatic cancer)
Publications
-
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
-
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
-
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma
-
PD-026Rechallenge with cetuximab + irinotecan in 3rd-line in RAS and BRAF wild-type metastatic colorectal cancer (mCRC) patients with acquired resistance to 1st-line cetuximab+irinotecan: The phase II CRICKET study by GONO.
-
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma
